Trial
NCT01963403
Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Davis
Collaborators
Washington University School of Medicine
Condition
Abnormal Uterine Bleeding, Unspecified
Intervention
EE 30mcg/LNG 150mcg
Why stopped
Futility of recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-12